239 related articles for article (PubMed ID: 18789525)
21. High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance.
Catts VS; Farnsworth ML; Haber M; Norris MD; Lutze-Mann LH; Lock RB
Leukemia; 2001 Jun; 15(6):929-35. PubMed ID: 11417479
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
Styczynski J; Kurylak A; Wysocki M
Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid receptors in lymphoid tumors.
Leventhal BG
Cancer Res; 1981 Nov; 41(11 Pt 2):4861-2. PubMed ID: 6975165
[TBL] [Abstract][Full Text] [Related]
24. Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines.
Beesley AH; Palmer ML; Ford J; Weller RE; Cummings AJ; Freitas JR; Firth MJ; Perera KU; de Klerk NH; Kees UR
Br J Cancer; 2006 Dec; 95(11):1537-44. PubMed ID: 17117183
[TBL] [Abstract][Full Text] [Related]
25. BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia.
van Galen JC; Kuiper RP; van Emst L; Levers M; Tijchon E; Scheijen B; Waanders E; van Reijmersdal SV; Gilissen C; van Kessel AG; Hoogerbrugge PM; van Leeuwen FN
Blood; 2010 Jun; 115(23):4810-9. PubMed ID: 20354172
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
Lauten M; Fernandez-Munoz I; Gerdes K; von Neuhoff N; Welte K; Schlegelberger B; Schrappe M; Beger C
Pediatr Blood Cancer; 2009 Apr; 52(4):459-63. PubMed ID: 19061214
[TBL] [Abstract][Full Text] [Related]
27. Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis.
Sionov RV; Cohen O; Kfir S; Zilberman Y; Yefenof E
J Exp Med; 2006 Jan; 203(1):189-201. PubMed ID: 16390935
[TBL] [Abstract][Full Text] [Related]
28. In vitro comparative antileukemic activity of various glucocorticoids in childhood acute leukemia.
Styczyński J; Wysocki M; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk A; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
Neoplasma; 2002; 49(3):178-83. PubMed ID: 12098004
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor.
Schmidt S; Irving JA; Minto L; Matheson E; Nicholson L; Ploner A; Parson W; Kofler A; Amort M; Erdel M; Hall A; Kofler R
FASEB J; 2006 Dec; 20(14):2600-2. PubMed ID: 17077285
[TBL] [Abstract][Full Text] [Related]
30. Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells.
Sai S; Nakagawa Y; Yamaguchi R; Suzuki M; Sakaguchi K; Okada S; Seckl JR; Ohzeki T; Chapman KE
Leuk Res; 2011 Dec; 35(12):1644-8. PubMed ID: 21794917
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines.
Hala M; Hartmann BL; Böck G; Geley S; Kofler R
Int J Cancer; 1996 Nov; 68(5):663-8. PubMed ID: 8938150
[TBL] [Abstract][Full Text] [Related]
32. Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia.
Samuels AL; Heng JY; Beesley AH; Kees UR
Br J Haematol; 2014 Apr; 165(1):57-66. PubMed ID: 24456076
[TBL] [Abstract][Full Text] [Related]
33. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
Gu L; Zhang G; Zhang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
[TBL] [Abstract][Full Text] [Related]
34. Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms.
Bray PJ; Cotton RG
Hum Mutat; 2003 Jun; 21(6):557-68. PubMed ID: 12754700
[TBL] [Abstract][Full Text] [Related]
35. Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.
Clarisse D; Van Wesemael K; Tavernier J; Offner F; Beck IM; De Bosscher K
PLoS One; 2018; 13(5):e0197000. PubMed ID: 29738549
[TBL] [Abstract][Full Text] [Related]
36. Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia.
Bachmann PS; Gorman R; Papa RA; Bardell JE; Ford J; Kees UR; Marshall GM; Lock RB
Cancer Res; 2007 May; 67(9):4482-90. PubMed ID: 17483364
[TBL] [Abstract][Full Text] [Related]
37. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid receptor gene polymorphisms and glucocorticoid sensitivity of subdermal blood vessels and leukocytes.
Kumsta R; Entringer S; Koper JW; van Rossum EF; Hellhammer DH; Wüst S
Biol Psychol; 2008 Oct; 79(2):179-84. PubMed ID: 18502562
[TBL] [Abstract][Full Text] [Related]
39. NFkappaB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia.
Nicholson L; Hall AG; Redfern CP; Irving J
Leuk Res; 2010 Oct; 34(10):1366-73. PubMed ID: 20106524
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.
Beesley AH; Firth MJ; Ford J; Weller RE; Freitas JR; Perera KU; Kees UR
Br J Cancer; 2009 Jun; 100(12):1926-36. PubMed ID: 19436302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]